A 23-year-old spray painter developed contact dermatitis and respiratory difficulty characerzed by small airways obstruction shordy after the polyfunctional aziridine crosslinker aX-100 began to be used in his workplace as a paint activator. The symptoms resolved after he was removed from the workplace and was treated with inhaled and topical steroids. 
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Case Presentation
A 23-year-old spray painter developed dermatitis and difficulty breathing after a new paint additive began to be used in his workplace in late December 1992. The rash began on his hands and progressed to his forearms, legs, and neck. The initial diagnosis was tinea corporis, and then asteototic dermatitis with nummular lesions. In January 1993, he was given nasal beclomethasone for congestion and an inhaler for breathing difficulties.
In February 1993, the patient was treated for bronchitis. By March, the rash was worse and he was given an albuterol inhaler for continued wheezing. He also had several episodes of eye irritation and redness and some periorbital and unilateral facial swelling.
During a 2-week vacation in July, the patient needed the bronchodilator less often.
The rash on his hand appeared unchanged, but he noted improvement in the pruritis and in the back ofhis neck and legs.
In August 1993, the patient was referred to occupational medicine for the dermatitis. He brought material safety data sheets for water-based low-bake enamel paints. The new paint additive was a polyfunctional aziridine cross-linker, CX-100 (1) . At this time, the patient was using diphenhydramine, inhaled albuterol, and topical triamcinolone. He 19% . This pattern was consistent with mild small airways disease. The patient had a 5% cross-shift drop in the peak expiratory flow rate on workdays. After he was removed from the workplace, the corresponding peak flow rates rose.
By September, the patient had been out of work for 1 week. His dermatitis had improved and his lungs were clear. He then left this job permanently.
In October, the patient was given a methacholine challenge test that showed a provocative concentration resulting in a 20% drop in the FEV1 (PC20) of 0.5 mg/mL (with < 8 mg/mL considered diagnostic of hyperreactive airways). The patient's dermatitis was resolved in all areas but the hands. He used a bronchodilator in the morning for chest tightness and cough and triamcinolone two puffs twice per day; he used fluocinonide cream for his hands.
In late October, the patient was prescribed triamcinolone cream and gloves at night for a vesicular eruption on his fingers. He discontinued inhaled steroids in late 1993 because of improvement. By April 1994, the rash on the right hand had resolved, but his left hand had a small lichenified, excoriated area. He used a bronchodilator three mornings per week and after exercise.
Past medical and occupational history. The patient denied childhood skin or respiratory problems and had never smoked. He noticed tears in his eyes when he was around cats. His identical twin got hives after bee stings.
The patient first worked in auto shops doing body work and painting. Then, as a technical student for 2 years, he spray-painted and refinished furniture. His most recent job (for 4 years) involved spray-painting furniture on an overhead conveyer belt, wearing a solvent respirator without eye protection. He stood between the furniture and the exhaust vent when spraying the back of each piece.
The painters added activator to the paint in a small room with a wall fan. (10) . Perhaps the most common exposures that may cause asthma in painters are diisocyantes such as toluene diisocyante, isophorone diisocyanate, hexamethylene diisocyanate (HDI), and prepolymers of HDI (10) . In one surveillance program, isocyanates were the reported causal agent in 22.2% of occupational asthma, and 28% of isocyanate-induced cases occurred in painters (6) . The case described here involved exposure to toluene diisocyanate, which causes bronchial asthma, skin irritation, and allergic eczema. In this case, the symptom onset coincided with exposure to another agent, but it is possible that longterm exposure to diisocyanates was a contributory sensitizing factor. The mean latency in those who have isocyanate-associated asthma between starting work and symptom onset is 7 years (11).
The importance of occupational exposures as causes ofasthma is underappreciated.
Estimates from surveillance studies (6, 12) (8, 9) , but because of narrowly defined exposures, the attributable risks must still be regarded as lower bounds (13) . A clinic-based case-control study found that the attributable risk of asthma due to manufacturing or service work was 33% (5) . A health maintenance organization-based prospective study of adultonset asthma, which examined both the potential occupational exposures and the relation of symptoms to the workplace, found that occupational exposure accounted for 21% of clinically significant adult-onset asthma cases (14) .
In many instances, immunologically mediated occupational asthma causes prolonged disability due to chronic airway inflammation (15) . The improvement in respiratory function in the current case may have resulted from the relatively short duration of exposure. Early workplace removal is associated with a better prognosis (15) . By 2 
a plateau and an evaluation of permanent impairment and disability can be conducted (15) .
The diagnosis of occupational asthma is based on a combination of history and objective tests (15, 16) . The history indudes typical respiratory symptoms associated with working and exposure to agents known to cause asthma. It may be less apparent that illness is work-related when symptoms occur in response to nonspecific irritants and are severe enough to last through the weekends (16) . The objective tests include serial pulmonary function testing to document variable airflow limitation and challenges to pharmacologic agents or the specific agent in question. Challenge tests can be falsely negative after the worker leaves the workplace for several days. Skin tests or radioallergosorbent tests for serum antibodies can establish sensitization to some agents, most ofwhich are of high-molecular weight (15) , such as latex.
The pattern observed on pharmacologic challenge is associated with the etiologic agent and the immunologic mechanism (15, 16) (Table 1) . Immunologically mediated asthma involves at least a short latency period. High-molecular weight agents (. 5,000 daltons) cause asthma by induction of IgE antibodies (15) . Some low-molecular weight agents such as acid anhydrides and platinum salts combine with a native protein to induce IgE antibodies. IgE-dependent reactions can involve an early asthmatic reaction, between several minutes and 2 hr after exposure (15) . Most low-molecular weight agents cause asthma through an IgEindependent immunologic mechanism. IgEindependent responses often involve a late asthmatic reaction, occurring between 4 and 48 hr after exposure. Biphasic responses, consisting of both early and late reactions, can occur following exposure to agents considered either IgE dependent or IgE independent (15) . Irritants, such as chlorine, can cause asthma without latency through undetermined mechanisms (15, 17, 18) .
The differential diagnosis includes several other respiratory conditions, including hypersensitivity pneumonitis (HP) and BOOP. HP, also termed extrinsic allergic alveolitis, can occur with chronic exposure to certain agents that also cause occupational asthma, such as diisocyanates. Although late HP is classically associated with a restrictive pattern on pulmonary function testing, HP can also cause small airways obstruction. The chest radiograph in chronic HP will generally involve a diffuse reticulonodular infiltrate, but may be normal early in the disease. Fever and other systemic symptoms are common, but are not always seen. Exposure to an agent that causes HP can sometimes be confirmed by checking for serum precipitins. Definitive diagnosis can be made by bronchoalveolar lavage or lung biopsy.
BOOP is often idiopathic, and frequently results in features not observed in this case, such as leukocytosis, crackles on lung auscultation, a restrictive pattern on pulmonary function testing, and patchy infiltrates on the chest radiograph. However, BOOP was not definitively excluded, given that the drops in the peak flow rate associated with work were small and no biopsy was performed. The positive methacholine response does not exclude BOOP, given that certain exposures can cause both BOOP and nonspecific bronchial hyperreactivity (19) .
This case demonstrates the importance of proper work practices. Rubber gloves were not always available. The patient did not wear a respirator during the mixing process. The respirator the patient wore during painting was designed to protect against solvents, as opposed to particulates. Moreover, the respirator did not protect the eyes. In addition, if the worker had been able to rotate the piece being painted, it would not have been necessary for him to be located between the paint being sprayed and the ventilation exhaust.
